Abstract:Abstract Background Emerging evidence indicates an immunomodulatory role of the appendix in ulcerative colitis (UC). Previous studies have suggested a beneficial effect of appendicectomy in inducing and maintaining remission. Therefore, appendicectomy may be considered as an alternative or adjunctive treatment in UC. Aim To evaluate the efficacy of appendicectomy in maintaining remission in UC patients. Methods Adult patients with established UC in complete clinical and endoscopic remission (defined as Mayo score <3 with endoscopic subscore of 0 or 1) following medical induction treatment for disease relapse within 12 months prior to randomisation, were enrolled in the Netherlands and United Kingdom. Patients were randomised (1:1) to undergo appendicectomy (intervention group) or continue maintenance medical therapy (control group). The primary outcome was the one-year UC relapse rate (defined as a total Mayo-score score ≥5 with endoscopic subscore of ≥2). To detect a clinically relevant decrease in relapse rate from 40% to 20%, 82 patients per study arm were needed to achieve 80% power. The last patient was included in September 2022, so analysis of the primary outcome parameter is expected to start soon. Trial progress, including the accumulated number of (serious) adverse events (SAE) in both groups, were presented annually to the Data Safety Monitoring Board. Therefore safety data is available. Results In total, 99 patients were included in the intervention group and 99 patients in the control group. There were 86 males and 112 females, with a median age of 41 years (IQR 33-52). Baseline characteristics were comparable in both groups, with the majority of patients having proctitis (38.9%) or left sided colitis (35.9%). Three SAEs were reported in the appendicectomy group, 2 of which were related to the surgical procedure (reintervention for obstructive ileus and postoperative hematoma) and one hospitalisation for clostridium infection. One SAE was reported within the first year in the control group (appendicitis). The one-year reported colitis-associated adverse event rate was significantly lower in the appendicectomy group when compared to the control group (46.4% vs. 63.9%, P=0.02). During follow up there were no colectomies in the appendicectomy group, whereas three patients underwent colectomy for therapy-refractory disease in the control group. Conclusion Appendicectomy in patients with UC has the possibility to decrease the rate of colitis-associated (serious) adverse events. These results suggest that the final analysis of the primary outcome parameter (relapse rate) could demonstrate that appendicectomy is superior to standard medical therapy alone in maintaining remission in these patients.

Association Between Prior Appendectomy and the Risk and Course of Crohn's Disease: A Systematic Review and Meta-Analysis.

Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood

Patients with Clostridium Difficile Infection and Prior Appendectomy May Be Prone to Worse Outcomes.

223 Does “prior Appendectomy” Affect the Outcomes of Clostridium Difficile Infection in Hospitalized Patients? A Retrospective Review and Analysis

Appendectomy and Risk of Subsequent Diverticular Disease Requiring Hospitalization: A Population-Based Case-Control Study

The association of appendectomy with prognosis and tumor-associated macrophages in patients with colorectal cancer

Beyond a vestigial organ: effects of the appendix on gut microbiome and colorectal cancer

Appendix removal affects the subsequent cancer risk in Asian adults: A territory-wide population-based cohort study

Appendectomy and risk of prostate cancer in the Health Professionals Follow-up Study

Altered gut microbiome composition by appendectomy contributes to colorectal cancer

The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis.

The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis

Appendectomy and appendicitis do not increase colorectal cancer risk: evidence from Mendelian randomization

Long-term impacts of appendectomy associated with increased incidence of inflammatory bowel disease, infection, and colorectal cancer

P955 The effect of appendicectomy on the clinical course of Ulcerative Colitis: Preliminary results

The impact of appendectomy on the occurrence of alopecia areata: A retrospective cohort study

The nexus between appendicitis and chronic inflammatory bowel diseases: Unraveling an intriguing association

The effect of cholecystectomy on the risk of colorectal cancer: A systematic review and meta-analysis

A Retrospective Cohort Study Based on Data from German General Practices

[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]

Prior Appendicectomy and Gut Microbiota Re-Establishment in Adults after Bowel Preparation and Colonoscopy